Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 1;37(1):15-21.
doi: 10.1097/HCO.0000000000000939.

Risk factors of sudden cardiac death in hypertrophic cardiomyopathy

Ying Hong  1   2   3 , Wilber W Su  4 , Xiaoping Li  2   3
Affiliations
Review

Risk factors of sudden cardiac death in hypertrophic cardiomyopathy

Ying Hong et al. Curr Opin Cardiol. .

Abstract

Purpose of review: Hypertrophic cardiomyopathy (HCM) is one of the leading causes of sudden cardiac death (SCD) in younger people and athletes. It is crucial to identify the risk factors for SCD in individuals with HCM. This review, based on recent systematic literature studies, will focus on the risk factors for SCD in patients with HCM.

Recent findings: An increasing number of studies have further explored the risk factors for SCD in patients with HCM, and new risk markers have emerged accordingly. In addition, more accurate SCD risk estimation and stratification methods have been proposed and continuously improved.

Summary: The identification of independent risk factors for HCM-related SCD would likely contribute to risk stratification. However, it is difficult to predict SCD with absolute certainty, as the annual incidence of SCD in adult patients with HCM is approximately 1%. The review discusses the established risk factors, such as a family history of SCD, unexplained syncope and some new risk factors. Taken together, the findings of this review demonstrate that there is a need for further research on individual risk factors and that SCD risk stratification in HCM patients remains a clinical challenge.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Box 1
Box 1
no caption available
See this image and copyright information in PMC

References

    1. Maron BJ, Olivotto I, Spirito P, et al. . Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large nonreferral-based patient population. Circulation 2000; 102:858–864. - PubMed
    1. Fananapazir L, Epstein ND. Prevalence of hypertrophic cardiomyopathy and limitations of screening methods. Circulation 1995; 92:700–704. - PubMed
    1. Zou Y, Song L, Wang Z, et al. . Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. Am J Med 2004; 116:14–18. - PubMed
    1. Semsarian C, Ingles J, Maron MS, et al. . New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 2015; 65:1249–1254. - PubMed
    1. Finocchiaro G, Papadakis M, Tanzarella G, et al. . Sudden death can be the first manifestation of hypertrophic cardiomyopathy: data from a United Kingdom Pathology Registry. JACC Clin Electrophysiol 2019; 5:252–254. - PubMed

Publication types